A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Volunteers · Primary Sclerosing Cholangitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

ICON, Salt Lake City, Utah, United States
Contact: Study coordinator (Site Contact) · 801-269-8200
Contact: Principal Investigator (Matthew D. Johnston, MD)

Study leads

Study Director
Takeda

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Impact of Exogenous Ketones on Breathing in Healthy Volunteers

Healthy Volunteer

Abroad (travel likely)RecruitingEARLY_PHASE1

Baltimore, United States

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

Healthy Volunteer

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

Healthy Volunteers · Alcohol Use Disorder (AUD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

Healthy Volunteers · Chronic Kidney Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Herston, Australia · Morayfield, Australia